Agomelatine Versus Fluoxetine in Glycemic Control and Treating Depressive and Anxiety Symptoms in Type 2 Diabetes Mellitus Subjects: A Single-Blind Randomized Controlled Trial
Neuropsychiatric Disease and Treatment
doi 10.2147/ndt.s167608
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2018
Authors
Publisher
Informa UK Limited